Cardinal Health, Inc. $CAH Shares Bought by Edmond DE Rothschild Holding S.A.

Edmond DE Rothschild Holding S.A. boosted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 51.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,682 shares of the company’s stock after acquiring an additional 1,927 shares during the period. Edmond DE Rothschild Holding S.A.’s holdings in Cardinal Health were worth $1,264,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in CAH. Downshift Financial LLC increased its holdings in Cardinal Health by 3,666.7% during the third quarter. Downshift Financial LLC now owns 113 shares of the company’s stock valued at $25,000 after buying an additional 110 shares during the period. Investors Research Corp purchased a new stake in Cardinal Health during the second quarter worth $29,000. Maryland Capital Advisors Inc. lifted its holdings in Cardinal Health by 12,600.0% during the third quarter. Maryland Capital Advisors Inc. now owns 127 shares of the company’s stock worth $28,000 after buying an additional 126 shares during the period. Allied Private Wealth LLC purchased a new stake in Cardinal Health during the second quarter worth $30,000. Finally, NBH Bank bought a new stake in Cardinal Health during the 2nd quarter valued at $31,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Cardinal Health stock opened at $272.67 on Friday. Cardinal Health, Inc. has a 1-year low of $180.45 and a 1-year high of $286.29. The business has a fifty day moving average price of $247.94 and a 200-day moving average price of $226.81. The stock has a market capitalization of $63.03 billion, a price-to-earnings ratio of 35.27, a PEG ratio of 2.09 and a beta of 0.53.

Cardinal Health (NYSE:CAH – Get Free Report) last announced its earnings results on Thursday, November 5th. The company reported $3.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.94 by $0.32. Cardinal Health had a negative return on equity of 102.72% and a net margin of 0.71%. The company had revenue of $67.51 billion for the quarter, compared to analyst estimates of $66.67 billion. During the same period in the prior year, the company posted $2.55 EPS. The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 12.96 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Investors of record on Monday, January 4th will be given a $0.5158 dividend. This represents a $2.06 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Monday, January 4th. Cardinal Health’s dividend payout ratio (DPR) is presently 26.65%.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on CAH. Citigroup lifted their price target on Cardinal Health from $265.00 to $280.00 and gave the company a “buy” rating in a report on Wednesday, August 12th. Barclays raised their price objective on Cardinal Health from $275.00 to $320.00 and gave the company an “overweight” rating in a research report on Wednesday. Weiss Ratings upgraded Cardinal Health from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Monday, November 9th. Royal Bank Of Canada lifted their target price on Cardinal Health from $276.00 to $295.00 and gave the company an “outperform” rating in a research note on Friday, November 6th. Finally, Wells Fargo & Company boosted their target price on shares of Cardinal Health from $277.00 to $321.00 and gave the stock an “overweight” rating in a report on Tuesday, November 17th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $290.13.

Read Our Latest Stock Report on CAH

About Cardinal Health

(Free Report)

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.

See Also

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.